Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands		Total	Total Stockholders’ Equity	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Noncontrolling Interests in Subsidiaries
Stockholders' equity, beginning of period (in shares) at Jan. 03, 2021				170,428
Stockholders' equity, beginning of period at Jan. 03, 2021		$ 406,486	$ 404,167	$ 170	$ 2,685,920	$ (205,476)	$ 8,799	$ (2,085,246)	$ 2,319
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(49,498)	(48,385)					(48,385)	(1,113)
Other comprehensive income		98	98				98
Issuance of restricted stock to employees, net of cancellations (in shares)				1,908
Issuance of restricted stock to employees, net of cancellations		2	2	$ 2
Stock-based compensation expense		5,437	5,437		5,437
Bond/debentures conversion (in shares)				4
Bond/debentures conversion		155	155		155
Purchases of treasury stock (in shares)				(76)
Purchases of treasury stock		(2,120)	(2,120)			(2,120)
Other adjustments		303	303		(89)			392
Stockholders' equity, end of period (in shares) at Apr. 04, 2021				172,264
Stockholders' equity, end of period at Apr. 04, 2021		360,863	359,657	$ 172	2,691,423	(207,596)	8,897	(2,133,239)	1,206
Stockholders' equity, beginning of period (in shares) at Jan. 03, 2021				170,428
Stockholders' equity, beginning of period at Jan. 03, 2021		406,486	404,167	$ 170	2,685,920	(205,476)	8,799	(2,085,246)	2,319
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income		576
Stockholders' equity, end of period (in shares) at Oct. 03, 2021				172,915
Stockholders' equity, end of period at Oct. 03, 2021		367,005	366,168	$ 172	2,711,769	(212,740)	9,375	(2,142,408)	837
Stockholders' equity, beginning of period (in shares) at Apr. 04, 2021				172,264
Stockholders' equity, beginning of period at Apr. 04, 2021		360,863	359,657	$ 172	2,691,423	(207,596)	8,897	(2,133,239)	1,206
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		74,769	75,207					75,207	(438)
Other comprehensive income		492	492				492
Issuance of restricted stock to employees, net of cancellations (in shares)				664
Issuance of common stock to executive (in shares)				101
Issuance of common stock to executive		2,999	2,999		2,999
Stock-based compensation expense		9,225	9,225		9,225
Purchases of treasury stock (in shares)				(187)
Purchases of treasury stock		(4,310)	(4,310)			(4,310)
Other adjustments		(25)	(25)			(25)
Stockholders' equity, end of period (in shares) at Jul. 04, 2021				172,842
Stockholders' equity, end of period at Jul. 04, 2021		444,013	443,245	$ 172	2,703,647	(211,931)	9,389	(2,058,032)	768
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(84,307)	(84,376)					(84,376)	69
Other comprehensive income		(14)	(14)				(14)
Issuance of restricted stock to employees, net of cancellations (in shares)				107
Issuance of restricted stock to employees, net of cancellations		0
Stock-based compensation expense		4,725	4,725		4,725
Purchases of treasury stock (in shares)				(34)
Purchases of treasury stock		(809)	(809)			(809)
Income taxes		3,397	3,397		3,397
Stockholders' equity, end of period (in shares) at Oct. 03, 2021				172,915
Stockholders' equity, end of period at Oct. 03, 2021		$ 367,005	366,168	$ 172	2,711,769	(212,740)	9,375	(2,142,408)	837
Stockholders' equity, beginning of period (in shares) at Jan. 02, 2022		173,051		173,051
Stockholders' equity, beginning of period at Jan. 02, 2022		$ 390,024	388,389	$ 173	2,714,500	(215,240)	11,168	(2,122,212)	1,635
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(28,460)	(27,871)					(27,871)	(589)
Other comprehensive income		2	2				2
Issuance of restricted stock to employees, net of cancellations (in shares)				1,201
Issuance of restricted stock to employees, net of cancellations		1	1	$ 1
Stock-based compensation expense		5,427	5,427		5,427
Purchases of treasury stock (in shares)				(407)
Purchases of treasury stock		(7,333)	(7,333)			(7,333)
Stockholders' equity, end of period (in shares) at Apr. 03, 2022				173,845
Stockholders' equity, end of period at Apr. 03, 2022		$ 359,661	358,615	$ 174	2,719,927	(222,573)	11,170	(2,150,083)	1,046
Stockholders' equity, beginning of period (in shares) at Jan. 02, 2022		173,051		173,051
Stockholders' equity, beginning of period at Jan. 02, 2022		$ 390,024	388,389	$ 173	2,714,500	(215,240)	11,168	(2,122,212)	1,635
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income		$ (71)
Stockholders' equity, end of period (in shares) at Oct. 02, 2022		174,155		174,155
Stockholders' equity, end of period at Oct. 02, 2022		$ 566,624	557,625	$ 174	2,845,845	(225,703)	11,097	(2,073,788)	8,999
Stockholders' equity, beginning of period (in shares) at Apr. 03, 2022				173,845
Stockholders' equity, beginning of period at Apr. 03, 2022		359,661	358,615	$ 174	2,719,927	(222,573)	11,170	(2,150,083)	1,046
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(62,327)	(63,112)					(63,112)	785
Other comprehensive income		(31)	(31)				(31)
Issuance of restricted stock to employees, net of cancellations (in shares)				359
Stock-based compensation expense		7,071	7,071		7,071
Purchases of treasury stock (in shares)				(123)
Purchases of treasury stock		(2,256)	(2,256)			(2,256)
Income taxes impact of sale of C&I Solutions business		(1,371)	(1,371)		(1,371)
Gain on sale of C&I Solutions business	[1]	118,344	114,401		114,401				3,943
Stockholders' equity, end of period (in shares) at Jul. 03, 2022				174,081
Stockholders' equity, end of period at Jul. 03, 2022		419,091	413,317	$ 174	2,840,028	(224,829)	11,139	(2,213,195)	5,774
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		142,632	139,407					139,407	3,225
Other comprehensive income		(42)	(42)				(42)
Issuance of restricted stock to employees, net of cancellations (in shares)				114
Stock-based compensation expense		6,557	6,557		6,557
Purchases of treasury stock (in shares)				(40)
Purchases of treasury stock		(874)	(874)			(874)
Closing statement adjustment in connection with the sale of our C&I Solutions business		$ (740)	(740)		(740)
Stockholders' equity, end of period (in shares) at Oct. 02, 2022		174,155		174,155
Stockholders' equity, end of period at Oct. 02, 2022		$ 566,624	$ 557,625	$ 174	$ 2,845,845	$ (225,703)	$ 11,097	$ (2,073,788)	$ 8,999

[1] As TotalEnergies Renewables is a subsidiary of TotalEnergies SE, our parent company, the sale of our C&I Solutions business was a transaction under common control. As such, total gain on sale of our C&I Solutions business was included in Additional Paid-in-Capital within our condensed consolidated statements of equity. Refer to Note 2. Discontinued Operations for further details.